Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis

Table 2

Survival analysis according to primary tumor type.

Primary tumor	Patients number (%)	Median survival time months (range)
Mesothelioma	43 (34.4)	11 (1–42)
Ovary	19 (15.2)	9.5 (1–40)
Gastroenterology	26 (20.8)	7 (2–18)
Liver, gall, and pancreas	24 (19.2)	6 (1–25)
Other	13 (10.4)	6 (1–13)
Overall	125 (100.0)	8 (1–42)